Equity Research —

Should You Buy Oaktree Specialty Lending Corpo Stock in 2026?

By CirclFi Research Team · · 9/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Oaktree Specialty Lending Corpo (OCSL) carries a solid Quality of Company rating of 6.4/10. Trading at $11.85, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 6 of 9 CirclFi valuation models project upside for Oaktree Specialty Lending Corpo (OCSL) at $11.85 — the model consensus leans bullish, with a Quality Score of 6.4/10 and Value-Trap risk of 8/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 6 of 9 models see upside — majority bullish
  • Quality Score: 6.4/10 — Moderate — mixed signals
  • Value Trap Risk: 8/100 — Minimal — healthy fundamentals
  • Fair Value Range: $1.76 – $37.05 (2009% spread)

Bullish Models

6 / 9

Bearish Models

3 / 9

Quality Score

6.4 /10

Moderate — mixed signals

Value Trap Risk

8 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

9 /13
Active Models

Avg. confidence: 29%

Investment Thesis

The Bull Case

Target: $37.05 (+212.7% upside)

  • According to the CirclFi Deep Alpha Valuation Engine, the gap between the market price of $11.85 and the composite fair value of $15.77 implies +33.1% upside potential.
  • According to the CirclFi Deep Alpha Valuation Engine, the ML Residual Income model targets a fair value of $37.05 (+212.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

The Bear Case

Target: $1.76 (-85.2%)

  • According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $1.76 (-85.2%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +297.9% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

Peer Benchmarking

PSEC Prospect Capital Cor
8.4
SCM Stellus Capital Inve
7.8
FDUS Fidus Investment Cor
7.6
HTGC Hercules Capital, In
7.6
GLAD Gladstone Capital Co
7.4

Valuation Divergence

Spread

2009%

Fair Value Range

$1.76 – $37.05

A 2009% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

ML-RIV

$37.05 (+212.7%)

Most Bearish

EROIC

$1.76 (-85.2%)

Key Risk Factors

Model Disagreement

2009% spread signals high variance in projections.

Macro/Sector Risk

— headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View OCSL Data Page →

The Bottom Line

The balance of evidence tilts cautiously positive for Oaktree Specialty Lending Corpo at $11.85. 6 of 9 models support upside to $15.77, backed by a 6.4/10 quality foundation. This is a "lean into, not load up on" setup in our framework.

These are quantitative model outputs, not investment recommendations. Oaktree Specialty Lending Corpo's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy OCSL stock right now?

Based on CirclFi's multi-model analysis, 6 of 9 models see upside for OCSL at $11.85. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 6.4/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Oaktree Specialty Lending Corpo?

Key risks include: wide model disagreement (2009% spread), signaling high uncertainty; general market and sector-specific risks affecting — companies. Always diversify and consult a financial advisor.

How does OCSL compare to its competitors?

Among — peers, OCSL holds a Quality Score of 6.4/10. Comparable companies include PSEC (QOC 8.4), SCM (QOC 7.8), FDUS (QOC 7.6). The relative ranking helps investors identify whether OCSL offers better fundamental quality than alternatives in the same sector.

Is OCSL a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. OCSL's Quality Score of 6.4/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy OCSL at?

CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $1.76 to $37.05. At $11.85, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for OCSL.

View OCSL Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →